Información del artículo
Catastrophic antiphospholipid syndrome (CAPS) is an unusual form of presentation of antiphospholipid syndrome with a poor prognosis, so early diagnosis and treatment are necessary. We report a patient who had gangrene as the initial manifestation of CAPS.
Key words:
Catastrophic antiphospholipid syndrome
Gangrene
Early diagnosis and treatment
El síndrome de anticuerpos antifosfolipídicos catastrófico (SAAFC) es una forma rara de presentación del síndrome de anticuerpos antifosfolipídicos, de mal pronóstico, por lo que son necesarios un diagnóstico y un tratamiento precoces. Presentamos un paciente que tuvo gangrena como manifestación inicial de un SAAFC.
Palabras clave:
Síndrome de anticuerpos antifosfolipídico catastrófico
Gangrena
Diagnóstico y tratamiento precoces
El Texto completo está disponible en PDF
References
[1.]
S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, R. Cervera, et al.
International consensus statement of an update of the classification criteria for definite antiphospholipid syndrome.
J Thromb Haemost, 4 (2006), pp. 295-306
[2.]
M. Khamashta, J. Font.
Síndrome antifosfolípido.
Lupus eritematoso sistémico, pp. 452-453
[3.]
M.D. Losckshin.
Síndrome de anticuerpos antifosfolipídicos.
Reumatología, pp. 1146-1147
[4.]
U.D. Bayraktar, D. Erkan, S. Bucciarelli, G. Espinosa, R.A. Asherson.
The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus.
J Rheumatol, 34 (2007), pp. 346-352
[5.]
G. Espinosa, R. Cervera, R.A. Asherson.
Catastrophic antiphospholipid syndrome and sepsis. A common link?.
J Rheumatol, 34 (2007), pp. 923-926
[6.]
R.A. Asherson.
Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.
Inmunobiology, 210 (2005), pp. 727-733
[7.]
R.A. Asherson, R. Cervera, P.G. de Groot, D. Erkan, M.C. Boffa, J.C. Piette.
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.
Lupus, 12 (2003), pp. 530-534
[8.]
R.A. Asherson, C. Frances, L. Iaccarino, M.A. Khamashta, F. Malacarne, J.C. Piette, et al.
The antiphospholipid antibody syndrome: diagnosis, skin manifestations and current therapy.
Clin Exp Rheumatol, 24 (2006), pp. 46-51
[9.]
H. Amital, Y. Levy, C. Davidson, I. Lundberg, A. Harju, Y. Kosach, et al.
Catastrophic antiphospholipid syndrome: remission following leg amputation in two cases.
Semin Arthritis Rheum, 31 (2001), pp. 127-132
[10.]
D. Erkan, R.A. Asherson, G. Espinosa, R. Cervera, J. Font, J.C. Piette, et al.
Long term outcome of catastrophic antiphospholipid síndrome survivors.
Ann Rheum Dis, 62 (2003), pp. 530-533
[11.]
S. Bucciarelli, G. Espinosa, R. Cervera, D. Erkan, J.A. Gómez-Puerta, M. Ra-mos-Casals, et al.
Mortality in the catastrophic antiphospholipid syndrome.
Arthritis Rheum, 54 (2006), pp. 2568-2576
Copyright © 2008. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
